What do radiation oncologists require for future advancements in lung SBRT?
- 1 December 2017
- journal article
- review article
- Published by Elsevier in Physica Medica
- Vol. 44, 150-156
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Outcomes of stereotactic ablative radiotherapy for central lung tumours: A systematic reviewRadiotherapy and Oncology, 2013
- Combining Radiotherapy and Cancer Immunotherapy: A Paradigm ShiftJNCI: Journal of the National Cancer Institute, 2013
- Impact of Introducing Stereotactic Lung Radiotherapy for Elderly Patients With Stage I Non–Small-Cell Lung Cancer: A Population-Based Time-Trend AnalysisJournal of Clinical Oncology, 2010
- Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trialLung Cancer, 2010
- Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung CancerJAMA, 2010
- Oligometastases and Oligo-recurrence: The New Era of Cancer TherapyJapanese Journal of Clinical Oncology, 2010
- Stage I nonsmall cell lung cancer in patients aged ≥75 yearsCancer, 2009
- Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung CancerJournal of Clinical Oncology, 2006
- Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinomaCancer, 2004
- Radiotherapy Alone for Medically Inoperable Stage I Non-Small–Cell Lung Cancer: The Duke ExperienceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1998